APA (7th ed.) Citation

Koch, R., Haveman, L., Ladenstein, R., Brichard, B., Jürgens, H., Cyprova, S., . . . Dirksen, U. (2023). Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial. Clinical cancer research, 29(24), . https://doi.org/10.1158/1078-0432.CCR-23-1966

Chicago Style (17th ed.) Citation

Koch, Raphael, et al. "Zoledronic Acid Add-on Therapy for Standard-risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial." Clinical Cancer Research 29, no. 24 (2023). https://doi.org/10.1158/1078-0432.CCR-23-1966.

MLA (9th ed.) Citation

Koch, Raphael, et al. "Zoledronic Acid Add-on Therapy for Standard-risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial." Clinical Cancer Research, vol. 29, no. 24, 2023, https://doi.org/10.1158/1078-0432.CCR-23-1966.